Role of proteasomes in transcription and their regulation by covalent modifications

Frontiers in Bioscience

Volumn 13, Issue 18, 2008, Pages 7184-7192

  Mittenberg, Alexey G ^a   Moiseeva, Tatyana N ^a   Barlev, Nickolai A ^a,b  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA Damage; Post Translational Modifications; Proteasome; Review; Transcription

Indexed keywords

PROTEASOME;

ALZHEIMER DISEASE; ANIMAL; CHROMATIN; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HOMEOSTASIS; HUMAN; METABOLISM; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REVIEW; RNA TRANSLATION; ULTRASTRUCTURE;

ALZHEIMER DISEASE; ANIMALS; CHROMATIN; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; PEPTIDE CHAIN ELONGATION, TRANSLATIONAL; PEPTIDE CHAIN TERMINATION, TRANSLATIONAL; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTION, GENETIC;

EID: 52049127000     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3220     Document Type: Article

References (90)

1. Baumeister W, J. Walz, F. Zuhl &E. Seemuller: The proteasome: paradigm of a self-compartmentalizing protease. Cell 92, 367-380 (1998) (Pubitemid 28093014)
2. Glickman M H &A. Ciechanover: The ubiquitinproteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82, 373-428 (2002) (Pubitemid 34654457)
3. Walz J, A. Erdmann, M. Kania, D. Typke, A. J. Koster &W. Baumeister: 26S proteasome structure revealed by three-dimensional electron microscopy. J Struct Biol 121, 19-29 (1998) (Pubitemid 28363249)
4. Voges D, P. Zwickl &W. Baumeister: The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 68, 1015-1068 (1999) (Pubitemid 29449214)
5. Dick T P, A. K. Nussbaum, M. Deeg, W. Heinemeyer, M. Groll, M. Schirle, W. Keilholz, S. Stevanovic, D. H. Wolf, R. Huber, H. G. Rammensee &H. Schild: Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants. J Biol Chem 273, 25637-25646 (1998) (Pubitemid 28475784)
6. Kisselev A F, T. N. Akopian, V. Castillo &A. L. Goldberg: Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. Mol Cell 4, 395-402 (1999) (Pubitemid 29499792)
7. Sikder D, S. A. Johnston &T. Kodadek: Widespread, but non-identical, association of proteasomal 19 and 20 S proteins with yeast chromatin. J Biol Chem 281, 27346-27355 (2006) (Pubitemid 44401762)
8. Szutorisz H, A. Georgiou, L. Tora &N. Dillon: The proteasome restricts permissive transcription at tissuespecific gene loci in embryonic stem cells. Cell 127, 1375-1388 (2006) (Pubitemid 44960411)
9. Zwaka T P: Keeping the noise down in ES cells. Cell 127, 1301-1302 (2006) (Pubitemid 44960422)
10. Ferdous A, F. Gonzalez, L. Sun, T. Kodadek &S. A. Johnston: The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol Cell 7, 981-991 (2001) (Pubitemid 32525745)
11. Sun L, S. A. Johnston &T. Kodadek: Physical association of the APIS complex and general transcription factors. Biochem Biophys Res Commun 296, 991-999(2002)
12. Fraser R A, M. Rossignol, D. J. Heard, J. M. Egly &P. Chambon: SUG1, a putative transcriptional mediator and subunit of the PA700 proteasome regulatory complex, is a DNA helicase. J Biol Chem 272, 7122-7126 (1997) (Pubitemid 27166417)
13. Lipford J R, G. T. Smith, Y. Chi &R. J. Deshaies: A putative stimulatory role for activator turnover in gene expression. Nature 438, 113-116 (2005) (Pubitemid 41599830)
14. Tansey W P: Death, destruction, and the proteasome. N Engl J Med 351, 393-394 (2004) (Pubitemid 38944411)
15. Kurosu T. &B. M. Peterlin: VP16 and ubiquitin; binding of P-TEFb via its activation domain and ubiquitin facilitates elongation of transcription of target genes. Curr Biol 14, 1112-1116 (2004) (Pubitemid 38791575)
16. Ferdous A, D. Sikder, T. Gillette, K. Nalley, T. Kodadek &S. A. Johnston: The role of the proteasomal ATPases and activator monoubiquitylation in regulating Gal4 binding to promoters. Genes Dev 21, 112-123 (2007) (Pubitemid 46089712)
17. Kodadek T, D. Sikder &K. Nalley: Keeping transcriptional activators under control. Cell 127, 261-264 (2006) (Pubitemid 44572383)
18. Rape M. &S. Jentsch: Productive RUPture: activation of transcription factors by proteasomal processing. Biochim Biophys Acta 1695, 209-213 (2004) (Pubitemid 39574974)
19. Kinyamu H. K. &T. K. Archer: Proteasome activity modulates chromatin modifications and RNA polymerase II phosphorylation to enhance glucocorticoid receptormediated transcription. Mol Cell Biol 27, 4891-4904 (2007) (Pubitemid 47016139)
20. Haupt Y, R. Maya, A. Kazaz &M. Oren: Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299 (1997) (Pubitemid 27220766)
21. Kubbutat M H, S. N. Jones &K. H. Vousden: Regulation of p53 stability by Mdm2. Nature 387, 299-303 (1997) (Pubitemid 27220767)
22. Higashitsuji H, Y. Liu, R. J. Mayer &J. Fujita: The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation. Cell Cycle 4, 1335-1337 (2005) (Pubitemid 41437115)
23. Gross-Mesilaty S, E. Reinstein, B. Bercovich, K. E. Tobias, A. L. Schwartz, C. Kahana &A. Ciechanover: Basaland human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc Natl Acad Sci U S A 95, 8058-8063 (1998) (Pubitemid 28326065)
24. Sears R C: The life cycle of C-myc: from synthesis to degradation. Cell Cycle 3, 1133-1137 (2004) (Pubitemid 40268631)
25. Zhang H, L. Sun, J. Liang, W. Yu, Y. Zhang, Y. Wang, Y. Chen, R. Li, X. Sun &Y. Shang: The catalytic subunit of theproteasome is engaged in the entire process of estrogen receptor-regulated transcription. EMBO J 25, 4223-4233 (2006) (Pubitemid 44435220)
26. Sdek P, H. Ying, D. L. Chang, W. Qiu, H. Zheng, R. Touitou, M. J. Allday &Z. X. Xiao: MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Mol Cell 20, 699-708 (2005) (Pubitemid 41740692)
27. Ying H. &Z. X. Xiao: Targeting retinoblastoma protein for degradation by proteasomes. Cell Cycle 5, 506-508 (2006) (Pubitemid 43340528)
28. Bae M H, C. H. Jeong, S. H. Kim, M. K. Bae, J. W. Jeong, M. Y. Ahn, S. K. Bae, N. D. Kim, C. W. Kim, K. R. Kim &K. W. Kim: Regulation of Egr-1 by association with the proteasome component C8. Biochim Biophys Acta 1592, 163-167 (2002)
29. Lukashchuk N. &K. H. Vousden: Ubiquitination and degradation of mutant p53. Mol Cell Biol 27, 8284-8295 (2007) (Pubitemid 350234240)
30. Asher G, P. Tsvetkov, C. Kahana &Y. Shaul: A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev 19, 316-321 (2005) (Pubitemid 40189294)
31. Kahana C, G. Asher &Y. Shaul: Mechanisms of protein degradation: an odyssey with ODC. Cell Cycle 4, 1461-1464 (2005)
32. Collins G. A. &W. P. Tansey: The proteasome: a utility tool for transcription? Curr Opin Genet Dev 16, 197-202 (2006) (Pubitemid 43376068)
33. Ezhkova E. &W. P. Tansey: Proteasomal ATPases link ubiquitylation of histone H2B to methylation of histone H3.Mol Cell 13, 435-442 (2004) (Pubitemid 38229815)
34. Gonzalez F, A. Delahodde, T. Kodadek &S. A. Johnston: Recruitment of a 19S proteasome subcomplex to an activated promoter. Science 296, 548-550 (2002) (Pubitemid 34408677)
35. Lee D, E. Ezhkova, B. Li, S. G. Pattenden, W. P. Tansey &J. L. Workman: The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcriptional activators. Cell 123, 423-436 (2005) (Pubitemid 41546673)
36. Ferdous A, T. Kodadek &S. A. Johnston: A nonproteolytic function of the 19S regulatory subunit of the 26S proteasome is required for efficient activated transcription by human RNA polymerase II. Biochemistry 41, 12798-12805 (2002) (Pubitemid 35192508)
37. Gillette T G, F. Gonzalez, A. Delahodde, S. A. Johnston &T. Kodadek: Physical and functional association of RNA polymerase II and the proteasome. Proc Natl Acad Sci U S A 101, 5904-5909 (2004) (Pubitemid 38520501)
38. Woudstra E C, C. Gilbert, J. Fellows, L. Jansen, J. Brouwer, H. Erdjument-Bromage, P. Tempst &J. Q. Svejstrup: A Rad26-Def1 complex coordinates repair and RNA pol II proteolysis in response to DNA damage. Nature 415, 929-933 (2002) (Pubitemid 34174757)
39. Somesh B P, J. Reid, W. F. Liu, T. M. Sogaard, H. Erdjument-Bromage, P. Tempst &J. Q. Svejstrup: Multiple mechanisms confining RNA polymerase II ubiquitylation to polymerases undergoing transcriptional arrest. Cell 121, 913-923 (2005) (Pubitemid 40806422)
40. Somesh B P, S. Sigurdsson, H. Saeki, H. Erdjument- Bromage, P. Tempst &J. Q. Svejstrup: Communication between distant sites in RNA polymerase II through ubiquitylation factors and the polymerase CTD. Cell 129, 57-68 (2007) (Pubitemid 46507583)
41. Anindya R, O. Aygun &J. Q. Svejstrup: Damageinduced ubiquitylation of human RNA polymerase II by the ubiquitin ligase Nedd4, but not cockayne syndrome proteins or BRCA1. Mol Cell 28, 386-397 (2007) (Pubitemid 350047546)
42. Krogan N J, M. H. Lam, J. Fillingham, M. C. Keogh, M. Gebbia, J. Li, N. Datta, G. Cagney, S. Buratowski, A. Emili &J. F. Greenblatt: Proteasome involvement in the repair of DNA double-strand breaks. Mol Cell 16, 1027-1034 (2004) (Pubitemid 40018411)
43. Reid J. &J. Q. Svejstrup: DNA damage-induced Def1- RNA polymerase II interaction and Def1 requirement for polymerase ubiquitylation in vitro. J Biol Chem; 279, 29875-29878 (2004) (Pubitemid 38937905)
44. Kleiman F E, F. Wu-Baer, D. Fonseca, S. Kaneko, R. Baer &J. L. Manley: BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II. Genes Dev 19, 1227-1237 (2005) (Pubitemid 40696188)
45. Kloetzel P M: Antigen processing by the proteasome. Nat Rev Mol Cell Biol 2, 179-187 (2001)
46. Kruger E, U. Kuckelkorn, A. Sijts &P. M. Kloetzel: The components of the proteasome system and their role in MHC class I antigen processing. Rev Physiol Biochem Pharmacol 148, 81-104 (2003)
47. Rivett A J, S. Bose, P. Brooks &K. I. Broadfoot: Regulation of proteasome complexes by gammainterferon and phosphorylation. Biochimie 83, 363-366 (2001) (Pubitemid 32293658)
48. Schwarz K, M. Eggers, A. Soza, U. H. Koszinowski, P. M. Kloetzel &M. Groettrup: The proteasomeregulator PA28alpha/beta can enhance antigen presentation without affecting 20S proteasome subunit composition. Eur J Immunol 30, 3672-3679 (2000) (Pubitemid 32005241)
49. Iwafune Y, H. Kawasaki &H. Hirano: Electrophoretic analysis of phosphorylation of the yeast 20S proteasome. Electrophoresis 23, 329-338 (2002) (Pubitemid 34157101)
50. Fernandez Murray P, P. S. Pardo, A. M. Zelada &S. Passeron: In vivo and in vitro phosphorylation of Candida albicans 20S proteasome. Arch Biochem Biophys 404, 116-125 (2002) (Pubitemid 34876287)
51. Bose S, G. G. Mason &A. J. Rivett: Phosphorylation of proteasomes in mammalian cells. Mol Biol Rep 26, 11-14 (1999) (Pubitemid 29223244)
52. Wang X, C. F. Chen, P. R. Baker, P. L. Chen, P. Kaiser &L. Huang: Mass spectrometric characterization of the affinity-purified human 26S proteasome complex. Biochemistry 46, 3553-3565 (2007) (Pubitemid 46449172)
53. Bose S, F. L. Stratford, K. I. Broadfoot, G. G. Mason &A. J. Rivett: Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon. Biochem J 378, 177-184 (2004) (Pubitemid 38299555)
54. Satoh K, H. Sasajima, K. I. Nyoumura, H. Yokosawa &H. Sawada: Assembly of the 26S proteasome is regulated by phosphorylation of the p45/Rpt6 ATPase subunit. Biochemistry 40, 314-319 (2001) (Pubitemid 32061978)
55. Thompson H G, J. W. Harris &J. P. Brody: Posttranslationally modified S12, absent in transformed breast epithelial cells, is not associated with the 26S proteasome and is induced by proteasome inhibitor. Int J Cancer 111, 338-347 (2004) (Pubitemid 38998813)
56. Ludemann R, K. M. Lerea &J. D. Etlinger: Copurification of casein kinase II with 20 S proteasomes and phosphorylation of a 30-kDa proteasome subunit. J Biol Chem 268, 17413-17417 (1993) (Pubitemid 23236982)
57. Iwafune Y, H. Kawasaki &H. Hirano: Identification of three phosphorylation sites in the alpha7 subunit ofthe yeast 20S proteasome in vivo using mass spectrometry. Arch Biochem Biophys 431, 9-15 (2004) (Pubitemid 39349353)
58. Zong C, A. V. Gomes, O. Drews, X. Li, G. W. Young, B. Berhane, X. Qiao, S. W. French, F. Bardag-Gorce &P. Ping: Regulation of murine cardiac 20S proteasomes: role of associating partners. Circ Res 99, 372-380 (2006) (Pubitemid 44253693)
59. Sumegi M, E. Hunyadi-Gulyas, K. F. Medzihradszky &A. Udvardy: 26S proteasome subunits are O-linked Nacetylglucosamine- modified in Drosophila melanogaster. Biochem Biophys Res Commun 312, 1284-1289 (2003) (Pubitemid 37490956)
60. Zhang F, K. Su, X. Yang, D. B. Bowe, A. J. Paterson &J. E. Kudlow: O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115, 715-725 (2003) (Pubitemid 38030300)
61. Kimura Y, M. Takaoka, S. Tanaka, H. Sassa, K. Tanaka, B. Polevoda, F. Sherman &H. Hirano: N (alpha)-acetylation and proteolytic activity of the yeast 20 S proteasome. J Biol Chem 275, 4635-4639 (2000) (Pubitemid 30108848)
62. Gomes A V, C. Zong, R. D. Edmondson, X. Li, E. Stefani, J. Zhang, R. C. Jones, S. Thyparambil, G. W. Wang, X. Qiao, F. Bardag-Gorce &P. Ping: Mapping the murine cardiac 26S proteasome complexes. Circ Res 99, 362-371 (2006) (Pubitemid 44253692)
63. Ullrich O, T. Reinheckel, N. Sitte, R. Hass, T. Grune &K. J. Davies: Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc Natl Acad Sci U S A 96, 6223-6228 (1999) (Pubitemid 29256647)
64. Kimura Y, Y. Saeki, H. Yokosawa, B. Polevoda, F. Sherman &H. Hirano: N-Terminal modifications of the 19S regulatory particle subunits of the yeast proteasome. Arch Biochem Biophys 409, 341-348 (2003) (Pubitemid 36259602)
65. Naujokat C. &S. Hoffmann: Role and function of the 26S proteasome in proliferation and apoptosis. Lab Invest 82, 965-980 (2002)
66. Sulahian R, D. Sikder, S. A. Johnston &T. Kodadek: The proteasomal ATPase complex is required for stressinduced transcription in yeast. Nucleic Acids Res 34, 1351-1357 (2006)
67. Tsimokha A S, A. G. Mittenberg, V. A. Kulichkova, I. V. Kozhukharova, L. N. Gause &I. M. Konstantinova: Changes in composition and activities of 26S proteasomes under the action of doxorubicin-apoptosis inductor of erythroleukemic K562 cells. Cell Biol Int 31, 338-348 (2007) (Pubitemid 46483107)
68. Hernandez-Vargas H, C. von Kobbe, C. Sanchez- Estevez, M. Julian-Tendero, J. Palacios &G. Moreno- Bueno: Inhibition of paclitaxel-induced proteasome activation influences paclitaxel cytotoxicity in breast cancer cells in a sequence-dependent manner. Cell Cycle 6, 2662-2668 (2007) (Pubitemid 350224050)
69. Ishii Y, S. Waxman &D. Germain: Targeting the ubiquitin-proteasome pathway in cancer therapy. Anticancer Agents Med Chem 7, 359-365 (2007) (Pubitemid 46813471)
70. Breitschopf K, A. M. Zeiher &S. Dimmeler: Ubiquitinmediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction. J Biol Chem 275, 21648-21652 (2000) (Pubitemid 30481872)
71. Grethe S, M. P. Ares, T. Andersson &M. I. Porn-Ares: p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x (L). Exp Cell Res 298, 632-642 (2004) (Pubitemid 38950878)
72. Fekete M R, W. H. McBride &F. Pajonk: Anthracyclines, proteasome activity and multi-drugresistance. BMC Cancer 5, 114 (2005)
73. Keller D M, X. Zeng, Y. Wang, Q. H. Zhang, M. Kapoor, H. Shu, R. Goodman, G. Lozano, Y. Zhao &H.Lu: A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. Mol Cell 7, 283-292 (2001) (Pubitemid 32206496)
74. Zhang F, Y. Hu, P. Huang, C. A. Toleman, A. J. Paterson &J. E. Kudlow: Proteasome function is regulatedby cyclic AMP-dependent protein kinase through phosphorylation of Rpt6. J Biol Chem 282, 22460-22471 (2007) (Pubitemid 47267329)
75. Reinheckel T, N. Sitte, O. Ullrich, U. Kuckelkorn, K. J. Davies &T. Grune: Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 335, (Pt 3) 637-642 (1998)
76. Jacquemont C. &T. Taniguchi: Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Cancer Res 67, 7395-7405 (2007) (Pubitemid 47206570)
77. Dahlmann B: Role of proteasomes in disease. BMC Biochem 8 Suppl 1, S3 (2007)
78. Fuchs D, C. Berges, G. Opelz, V. Daniel &C. Naujokat: Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells. J Cell Biochem 103, 270-283 (2007)
79. Naujokat C, D. Fuchs &C. Berges: Adaptive modification and flexibility of the proteasome system in response to proteasome inhibition. Biochim Biophys Acta 1773, 1389-1397 (2007) (Pubitemid 47374847)
80. Benedict C M, L. Ren &G. A. Clawson: Nuclear multicatalytic proteinase alpha subunit RRC3: differentialsize, tyrosine phosphorylation, and susceptibility to antisense oligonucleotide treatment. Biochemistry 34, 9587-9598 (1995)
81. Wehren A, H. E. Meyer, A. Sobek, P. M. Kloetzel &B. Dahlmann: Phosphoamino acids in proteasome subunits.Biol Chem 377, 497-503 (1996) (Pubitemid 26383900)
82. Mason G G, K. B. Hendil &A. J. Rivett: Phosphorylation of proteasomes in mammalian cells. Identification of two phosphorylated subunits and the effect of phosphorylation on activity. Eur J Biochem 238, 453-462 (1996)
83. Feng Y, D. L. Longo &D. K. Ferris: Polo-like kinase interacts with proteasomes and regulates their activity. Cell Growth Differ 12, 29-37 (2001) (Pubitemid 32107510)
84. Castano J G, E. Mahillo, P. Arizti &J. Arribas: Phosphorylation of C8 and C9 subunits of the multicatalytic proteinase by casein kinase II and identification of the C8 phosphorylation sites by direct mutagenesis. Biochemistry 35, 3782-3789 (1996) (Pubitemid 26102167)
85. Horiguchi R, M. Yoshikuni, M. Tokumoto, Y. Nagahama &T. Tokumoto: Identification of a protein kinase which phosphorylates a subunit of the 26S proteasome and changes in its activity during meiotic cell cycle in goldfish oocytes. Cell Signal 17, 205-215 (2005) (Pubitemid 39371048)
86. Umeda M, N. Fujii, Y. Manabe &H. Uchimiya: Molecular and biochemical characterization of a proteasome subunit from rice and carrot cells. Mol Gen Genet 255, 19-27 (1997)
87. Bose S, P. Brooks, G. G. Mason &A. J. Rivett: Gamma-interferon decreases the level of 26 S proteasomes and changes the pattern of phosphorylation. Biochem J 353, 291-297 (2001) (Pubitemid 32096938)
88. Gillardon F, A. Kloss, M. Berg, M. Neumann, K. Mechtler, B. Hengerer &B. Dahlmann: The 20S proteasome isolated from Alzheimer's disease brain shows post-translational modifications but unchanged proteolytic activity. J Neurochem 101, 1483-1490 (2007) (Pubitemid 46848842)
89. Pardo P S, P. F. Murray, K. Walz, L. Franco &S. Passeron: In vivo and in vitro phosphorylation of the alpha 7/PRS1 subunit of Saccharomyces cerevisiae 20 Sproteasome: in vitro phosphorylation by protein kinase CK2 is absolutely dependent on polylysine. Arch Biochem Biophys 349, 397-401 (1998) (Pubitemid 28368687)
90. Satoh K, T. Nishikawa, H. Yokosawa &H. Sawada: Phosphorylation of proteasome substrate by a protein kinase associated with the 26 S proteasome is linked to the ATP-dependent proteolysis of the 26 Sproteasome. Biochem Biophys Res Commun 213, 7-14 (1995)